Humana Inc., a leading U.S.
healthcare company, has released a comprehensive Value-Based Care (VBC) Issue Brief focused on nephrology. This pioneering brief demonstrates how VBC arrangements can significantly improve patient outcomes and reduce healthcare costs for people with chronic kidney disease (CKD) and end-stage renal disease (ESRD). “Kidney disease is a challenging diagnosis for patients to face.
The prognosis is tough, and treatment is costly and burdensome for patients,” said Dr. Kate Goodrich, Chief Medical Officer at Humana. “Value-based care’s emphasis on primary care physicians (PCP), specialists, care teams, and patients working together to delay the most difficult outcomes through preventive and preemptive steps gives patients and their providers hope and a plan forward during that difficult time.
It keeps everyone in alignment toward better results.” VBC incentivizes healthcare providers for patient outcomes and quality, fundamentally different from fee-for-service models, which incentivize healthcare providers for the number of patients and procedures. Humana is leveraging expertise and success within VBC in primary care, expanding into the specialty care space, including this VBC Issue Brief on kidney care.
The need for innovative approaches to kidney care is more critical than ever. Chronic kidney disease affects more than one in seven adults (an estimated 37 million people) in the United States and is often linked to diabetes and high blood pres.
